Oxford Nanopore
@nanoporetech.com
🌍Direct DNA/RNA analysis for anyone, anywhere
🧬Short to ultra-long reads in real-time for rapid insights
🔬Products for research use only
🧬Short to ultra-long reads in real-time for rapid insights
🔬Products for research use only
This month's Science Unlocked covers adaptation to genetic bottlenecks, cell-free DNA sequencing, and microbiome research. These studies showcase the advances in scientific research made possible by Oxford Nanopore technology.
Read here: https://bit.ly/4rdi4Yx
Read here: https://bit.ly/4rdi4Yx
September 16, 2026 at 9:03 AM
This month's Science Unlocked covers adaptation to genetic bottlenecks, cell-free DNA sequencing, and microbiome research. These studies showcase the advances in scientific research made possible by Oxford Nanopore technology.
Read here: https://bit.ly/4rdi4Yx
Read here: https://bit.ly/4rdi4Yx
258 cancer genes. One assay. Real answers.
Discover how Oxford Nanopore’s hereditary cancer panel reveals what others miss.
Discover more: https://nanoporetech.com/hereditary-cancer-panel?utm_campaign=Clinical+cancer+26&utm_content=1789490701&utm_medium=social&utm_source=bluesky
Discover how Oxford Nanopore’s hereditary cancer panel reveals what others miss.
Discover more: https://nanoporetech.com/hereditary-cancer-panel?utm_campaign=Clinical+cancer+26&utm_content=1789490701&utm_medium=social&utm_source=bluesky
September 15, 2026 at 4:45 PM
258 cancer genes. One assay. Real answers.
Discover how Oxford Nanopore’s hereditary cancer panel reveals what others miss.
Discover more: https://nanoporetech.com/hereditary-cancer-panel?utm_campaign=Clinical+cancer+26&utm_content=1789490701&utm_medium=social&utm_source=bluesky
Discover how Oxford Nanopore’s hereditary cancer panel reveals what others miss.
Discover more: https://nanoporetech.com/hereditary-cancer-panel?utm_campaign=Clinical+cancer+26&utm_content=1789490701&utm_medium=social&utm_source=bluesky
New in Neuro-Oncology: researchers at Princess Máxima Center report on Sturgeon, their AI-based tool built on nanopore sequencing, used in their own paediatric neurosurgical workflow to help inform real-time surgical decisions. https://bit.ly/4y5v1pI
RUO
RUO
September 14, 2026 at 4:12 PM
New in Neuro-Oncology: researchers at Princess Máxima Center report on Sturgeon, their AI-based tool built on nanopore sequencing, used in their own paediatric neurosurgical workflow to help inform real-time surgical decisions. https://bit.ly/4y5v1pI
RUO
RUO
Not all biological answers lie in the DNA sequence. In this knowledge exchange, explore how gold-standard methylation sequencing with Oxford Nanopore reveals hidden insights that traditional methods miss — all from a single run.
Register here: https://bit.ly/4xoxqed
Register here: https://bit.ly/4xoxqed
September 11, 2026 at 1:55 PM
Not all biological answers lie in the DNA sequence. In this knowledge exchange, explore how gold-standard methylation sequencing with Oxford Nanopore reveals hidden insights that traditional methods miss — all from a single run.
Register here: https://bit.ly/4xoxqed
Register here: https://bit.ly/4xoxqed
Have questions about EPI2ME? Now’s your chance to ask them! Head over to the Nanopore Community and add your questions for our EPI2ME experts to reply to them directly in the thread.
Submit your questions now: https://bit.ly/4heKkqu
Submit your questions now: https://bit.ly/4heKkqu
September 10, 2026 at 2:32 PM
Have questions about EPI2ME? Now’s your chance to ask them! Head over to the Nanopore Community and add your questions for our EPI2ME experts to reply to them directly in the thread.
Submit your questions now: https://bit.ly/4heKkqu
Submit your questions now: https://bit.ly/4heKkqu
Unbox the world’s smallest and most accessible sequencer.
The MinION Mk1D is portable yet powerful, ideal for labs looking for rapid results without compromise. Simply plug it into your laptop and start sequencing, whether in the lab or in the field. https://bit.ly/4x6HfgR
The MinION Mk1D is portable yet powerful, ideal for labs looking for rapid results without compromise. Simply plug it into your laptop and start sequencing, whether in the lab or in the field. https://bit.ly/4x6HfgR
September 9, 2026 at 5:08 PM
Unbox the world’s smallest and most accessible sequencer.
The MinION Mk1D is portable yet powerful, ideal for labs looking for rapid results without compromise. Simply plug it into your laptop and start sequencing, whether in the lab or in the field. https://bit.ly/4x6HfgR
The MinION Mk1D is portable yet powerful, ideal for labs looking for rapid results without compromise. Simply plug it into your laptop and start sequencing, whether in the lab or in the field. https://bit.ly/4x6HfgR
Does more mRNA in a tissue mean more protein made? Not necessarily. A new preprint from Monash University used nanopore sequencing to track LNP-delivered mRNA in mice and found a clear disconnect between mRNA delivery and protein expression across organs. https://bit.ly/4hTpcXH
September 9, 2026 at 12:56 PM
Does more mRNA in a tissue mean more protein made? Not necessarily. A new preprint from Monash University used nanopore sequencing to track LNP-delivered mRNA in mice and found a clear disconnect between mRNA delivery and protein expression across organs. https://bit.ly/4hTpcXH
Last week, Sky News featured a programme, pioneered by Guy's and St Thomas' NHS Foundation Trust & being expanded through the NHS, which is exploring how rapid metagenomic sequencing can characterise unknown pathogens in clinical & public health settings.
https://bit.ly/3VhUcHi
https://bit.ly/3VhUcHi
September 9, 2026 at 8:53 AM
Last week, Sky News featured a programme, pioneered by Guy's and St Thomas' NHS Foundation Trust & being expanded through the NHS, which is exploring how rapid metagenomic sequencing can characterise unknown pathogens in clinical & public health settings.
https://bit.ly/3VhUcHi
https://bit.ly/3VhUcHi
Methylation is becoming a key biomarker in neurodegenerative disease. As Kim Billingsley put it, you need to see the variant and the epigenetics together on the same molecule, in the same run. With nanopore, you get that for free, without needing a separate assay. #Nanoporeconf
September 7, 2026 at 1:20 PM
Methylation is becoming a key biomarker in neurodegenerative disease. As Kim Billingsley put it, you need to see the variant and the epigenetics together on the same molecule, in the same run. With nanopore, you get that for free, without needing a separate assay. #Nanoporeconf
Still relying on legacy approaches for microbial analysis? Join this webinar to discover the latest tools for resolving strain-level diversity, recovering complete genomes, and unlocking deeper insights from complex microbial communities.
Register here: https://bit.ly/3UnBy0r
Register here: https://bit.ly/3UnBy0r
September 4, 2026 at 2:09 PM
Still relying on legacy approaches for microbial analysis? Join this webinar to discover the latest tools for resolving strain-level diversity, recovering complete genomes, and unlocking deeper insights from complex microbial communities.
Register here: https://bit.ly/3UnBy0r
Register here: https://bit.ly/3UnBy0r
Earlier cancer detection can change outcomes. Explore how Oxford Nanopore sequencing is helping researchers extract more information from a single liquid biopsy, opening new possibilities for non-invasive cancer monitoring. https://bit.ly/4iuxF3F
September 2, 2026 at 12:39 PM
Earlier cancer detection can change outcomes. Explore how Oxford Nanopore sequencing is helping researchers extract more information from a single liquid biopsy, opening new possibilities for non-invasive cancer monitoring. https://bit.ly/4iuxF3F
New in Nature Communications: Amgen deCODE genetics sequenced 7,284 genomes on Oxford Nanopore, delivering gold-standard methylation calls. They found 702 CpG units where ageing impacts maternal & paternal alleles differently, beyond the reach of arrays. https://bit.ly/4qEn4W5
September 1, 2026 at 12:03 PM
New in Nature Communications: Amgen deCODE genetics sequenced 7,284 genomes on Oxford Nanopore, delivering gold-standard methylation calls. They found 702 CpG units where ageing impacts maternal & paternal alleles differently, beyond the reach of arrays. https://bit.ly/4qEn4W5
6 studies show nanopore sequencing ID'ing bloodstream infections in <3.5 hrs, cutting AMR turnaround by up to 20 hrs, and catching culture-negative pathogens standard tests missed entirely. Real-time genomics is changing infectious disease response. https://bit.ly/3S8Fxxi
August 31, 2026 at 4:07 PM
6 studies show nanopore sequencing ID'ing bloodstream infections in <3.5 hrs, cutting AMR turnaround by up to 20 hrs, and catching culture-negative pathogens standard tests missed entirely. Real-time genomics is changing infectious disease response. https://bit.ly/3S8Fxxi
Outbreak missed by routine surveillance. Caught by genomic surveillance. Max Bloomfield's research on infection control genomics is a great example of why real-time, precise data matters. https://bit.ly/3TrNq0K
August 28, 2026 at 4:58 PM
Outbreak missed by routine surveillance. Caught by genomic surveillance. Max Bloomfield's research on infection control genomics is a great example of why real-time, precise data matters. https://bit.ly/3TrNq0K
Chanatjit Cheawsamoot shared how nanopore sequencing delivers data the current standard of care misses and are now considering it earlier in the diagnostic pathway, rather than as a last‑resort test.
August 27, 2026 at 8:43 PM
Chanatjit Cheawsamoot shared how nanopore sequencing delivers data the current standard of care misses and are now considering it earlier in the diagnostic pathway, rather than as a last‑resort test.
100 million people in Africa live with rare diseases — most uncharacterised. At Stellenbosch University, nanopore sequencing has the potential to change that, delivering faster answers and bringing equitable access to genomic medicine closer to reality.
August 26, 2026 at 12:59 PM
100 million people in Africa live with rare diseases — most uncharacterised. At Stellenbosch University, nanopore sequencing has the potential to change that, delivering faster answers and bringing equitable access to genomic medicine closer to reality.
Oxford Nanopore today announces the appointment of David Miller as Chief Development and Product Officer (CDPO) and Conor McKechnie as Chief Marketing and Communications Officer (CMCO), joining on 1st September and 1st October respectively.
https://bit.ly/3UkiUqb
https://bit.ly/3UkiUqb
August 25, 2026 at 12:57 PM
Oxford Nanopore today announces the appointment of David Miller as Chief Development and Product Officer (CDPO) and Conor McKechnie as Chief Marketing and Communications Officer (CMCO), joining on 1st September and 1st October respectively.
https://bit.ly/3UkiUqb
https://bit.ly/3UkiUqb
In this webinar, Marilyn Li shares data from her team’s work at Children’s Hospital of Philadelphia applying real-time Oxford Nanopore sequencing to classify acute leukaemia and tumours in minutes. Learn more: https://bit.ly/3OtB4mY
For research use only.
For research use only.
August 24, 2026 at 3:42 PM
In this webinar, Marilyn Li shares data from her team’s work at Children’s Hospital of Philadelphia applying real-time Oxford Nanopore sequencing to classify acute leukaemia and tumours in minutes. Learn more: https://bit.ly/3OtB4mY
For research use only.
For research use only.
Faster infection detection. Richer microbial insights. Dive into some of the standout metagenomics talks from London Calling 2026 and discover the workflows, protocols, and masterclasses to help you get started with Oxford Nanopore metagenomic sequencing. https://bit.ly/4wEYXZp
August 21, 2026 at 6:04 PM
Faster infection detection. Richer microbial insights. Dive into some of the standout metagenomics talks from London Calling 2026 and discover the workflows, protocols, and masterclasses to help you get started with Oxford Nanopore metagenomic sequencing. https://bit.ly/4wEYXZp
"This approach can facilitate access to precision therapies" — detecting alterations standard NGS finds tricky to capture. Dr. Vincent Philippe Lavallee on Oxford Nanopore sequencing research in paediatric oncology. RUO (research use only) https://bit.ly/4w1x3Xi
August 20, 2026 at 2:10 PM
"This approach can facilitate access to precision therapies" — detecting alterations standard NGS finds tricky to capture. Dr. Vincent Philippe Lavallee on Oxford Nanopore sequencing research in paediatric oncology. RUO (research use only) https://bit.ly/4w1x3Xi
Today we announce our results for H1 2026. Revenue increased to £116.7 million, up 12.3% at constant currency, while gross margin improved by 400bps to 62.2%.
Read the full H1 2026 results: https://bit.ly/3SCOOh8
Read the full H1 2026 results: https://bit.ly/3SCOOh8
August 19, 2026 at 8:43 AM
Today we announce our results for H1 2026. Revenue increased to £116.7 million, up 12.3% at constant currency, while gross margin improved by 400bps to 62.2%.
Read the full H1 2026 results: https://bit.ly/3SCOOh8
Read the full H1 2026 results: https://bit.ly/3SCOOh8
Running samples one by one limits how far your study can go. The cDNA Barcoding Kit lets you run more RNA samples together, making it easier to move beyond small pilots and generate datasets big enough to actually answer your research question. https://bit.ly/4aECDGi
August 18, 2026 at 1:21 PM
Running samples one by one limits how far your study can go. The cDNA Barcoding Kit lets you run more RNA samples together, making it easier to move beyond small pilots and generate datasets big enough to actually answer your research question. https://bit.ly/4aECDGi
What if the clues to neurodegenerative disease have been hiding in plain sight? Kimberley Billingsley & the NIH team discovered thousands of transcripts missed by short-read sequencing, unlocking a deeper view of Alzheimer’s & Parkinson’s mechanisms. https://bit.ly/4q0mCAX
August 17, 2026 at 1:46 PM
What if the clues to neurodegenerative disease have been hiding in plain sight? Kimberley Billingsley & the NIH team discovered thousands of transcripts missed by short-read sequencing, unlocking a deeper view of Alzheimer’s & Parkinson’s mechanisms. https://bit.ly/4q0mCAX
New study from Jessa Hospital reports the first published in-house clinical validation of SQK-MAB114.24. Researchers achieved same-day 16S results in <7h & detected additional clinically relevant pathogens in culture-negative & polymicrobial infections. https://bit.ly/4wUNqFJ
August 13, 2026 at 3:12 PM
New study from Jessa Hospital reports the first published in-house clinical validation of SQK-MAB114.24. Researchers achieved same-day 16S results in <7h & detected additional clinically relevant pathogens in culture-negative & polymicrobial infections. https://bit.ly/4wUNqFJ
If you’re a researcher, you’ll know that benchmarking data is an important tool. In this Q&A with our Director of Applications Bioinformatics, discover what benchmarking really means, why it matters, and how to make the most of benchmarking data. https://bit.ly/44nUIoP
August 11, 2026 at 1:07 PM
If you’re a researcher, you’ll know that benchmarking data is an important tool. In this Q&A with our Director of Applications Bioinformatics, discover what benchmarking really means, why it matters, and how to make the most of benchmarking data. https://bit.ly/44nUIoP